Building Health Check Provides Halo Disinfection System Approved by EPA for Disinfection Dramatically Lowers Healthcare-Acquired C. DIFF Infection Rates

During a recent study of the Halo Disinfection System™ (HDS) system at Pennsylvania Hospital, a 496-bed urban teaching hospital in Philadelphia, PA, infection control experts cut the rate of C. diff infections by 66% after deploying the HDS system in patient rooms, operating rooms and treatment areas.

Tampa, FL — Building Health Check, LLC, a reseller (distributor) and marketer of the Halo Disinfection System™, which eliminates 99.9999% of Clostridium difficile (C. diff) spores in entire rooms announced the registration with the United States Environmental Protection Agency (EPA Registration No. 84526-6). It is the first disinfectant fogging system validated by the EPA to kill Clostridium difficile (C. diff) spores.

The Halo Disinfection System™ also kills many other pathogens typically found in hospitals and healthcare environments using a patented solution of hydrogen peroxide and ionic silver applied in a dry mist by a cost-effective portable fogger.


The Halo Disinfection System incorporates the HaloFogger™ using the healthcare-grade HaloMist™ solution. The system is an easy-to-use, economic and highly effective alternative to “spray & wipe”, UV light and other disinfecting strategies. During hands-free use, the HaloFogger converts the HaloMist into a clear, odorless dry mist that reaches in and around every surface in an enclosed area. There is no need to mix the solution, nor is there any need for rinsing or wiping.

After application, HaloMist decomposes into water and oxygen molecules, dries on contact and does not harm sensitive medical equipment. The system does not contain or produce chlorine, hypochlorite (bleach), alcohol, aldehydes, phenols, ammonium compounds or sodium hydroxide. These toxins and harsh chemicals can be found in many other disinfecting solutions.

During a recent study of the HDS system at Pennsylvania Hospital, a 496-bed urban teaching hospital in Philadelphia, PA, infection control experts cut the rate of C. diff infections by 66% after deploying the HDS system in patient rooms, operating rooms and treatment areas. In a similar study, Southwestern Vermont Medical Center experienced a period of more than 6 months without a single hospital-acquired C. diff case. These results suggest that the system offers a comparatively simple, inexpensive way to comply with a federal mandate to reduce C. diff HAI infections 30% by 2016.

For healthcare facilities, educational facilities and commercial facilities interested in purchasing the revolutionary HDS product line contact Building Health Check account executive Chris Lane at 1-800-422-7873 ext 303. For those interested in distributing the Halo Disinfecting system and/or carrying the IAQ Screen Check product line can contact Chris Lane at 800-422-7873 ext 303.
If you are interested in having your facility treated with the revolutionary HDS call Pure Air Control Services (PURE-Decon room disinfecting treatment) at 1-800-422-7873 ext 802.

About Building Health Check LLC

Building Health Check, LLC sets the industry standard for disinfecting equipment, IAQ DIY kits, testing equipment, and laboratory analysis. Building Health Check has affiliations with EDLab and Accustar Labs.

Building Health Checks, LLC’s expanding client roster includes: Hunter Fans, WW Grainger, Progressive Insurance, USACE, Southern California Schools JPA, VA Medical Center, Broward General Healthcare, General Services Administration (GSA); Allstate Insurance; Carrier Air Conditioning; and, CB Richard Ellis and many other Fortune 500 companies, school boards, and city, state, and county governments, making Building Health Check, LLC the reliable industry leader in DIY IAQ testing.

For more information on Building Health Check, LLC or EDLab please contact Dr. Rajiv Sahay or Chris Lane at 727-572-4550, (800) 422-7873 ext 303 or visit www.indoorairtest.com

It's only fair to share...Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn